Managing Sustainable Breakthrough Innovation

Similar documents
DSM perspective on Innovation-driven growth

Life Sciences and Material Sciences

Driving sustainable growth through innovation Rob van Leen, Chief Innovation Officer & Member Executive Committee Delft, September 25, 2017

Biobased ECO+ Solutions from DSM

The Biotech Revolution in Europe What s needed to make it happen?

CORBION: DEVELOPING A BIOBASED PORTFOLIO

Staying the Course. Life Sciences and Materials Sciences. Feike Sijbesma Chairman Managing Board. December 3, 2009 Merrill Lynch Conference, London

DSM Food Specialties. Gregory Kesel, President DSM Food Specialties Americas. US Field Trip September 4, 2014

Tom Connelly Executive Vice President & Chief Innovation Officer Industrial Biosciences and Performance Materials

Platts Renewable Chemicals Conference JW Marriott, Houston, Texas. September 12, Pulakesh Mukherjee BASF Venture Capital

Innovation Ecosystem for a Smarter Planet

Sustainable Succinic Acid

NOVOZYMES & RENEWABLE CHEMICALS

Can the world s strongest medical grade fiber help you to design your next device?

Alliqua BioMedical Investor Presentation August 2017 NASDAQ: ALQA

The next generation of bio-performance materials

Novozymes Conference Call 1H August 11, 2017

Welcome to PRAJ Industries Ltd

Corporate Entrepreneurship and Business Innovation. Scott Bowman Partner, Clareo

Future Pharma - Challenges & Trends MES Process & Minds Conference Berlin, Germany, September 2015

Spinverse. Your Emerging Technology Partner. Transnational corporations and Russian Companies collaboration in the area of R&D

Horizon 2020 funding opportunities for Regenerative Medicine ( ) Rudolf Fryček, PhD.

A materials toolbox for medical technology

A Primer for budding entrepreneurs: I think I have a great idea, now what? Background on Confluent The Primer Discussion

Is renewable succinic acid a commercial reality?

Global Cellulosic Ethanol Industry 2015 Market Research Report

Creating New Business. In a Large Company. Dr. Lee Ng. Business Director. New Business Creation

Investor Presentation. November 26, 2013

Tissue Engineered Medical Products

Capital Markets Day 2016 Commercial Transformation growing faster than the market through differentiation. Gérard Kuperfarb, Growth & Innovation

Nanotechnology and the Agenda 2020 Industry Technology Vision

Q Financial Results Presentation. Investor Relations

McKinsey Center for Government What's Driving the Recent Surge in New Drug Approvals?

Lignin Extraction Process Plant Residues for Green Chemistry and Biogas. Berlin,

Food and Energy Security through Sustainable Life Sciences. BIO Pacific Rim 2014 December 8, 2014

Farm Bill Energy Title Programs

Collagen Solutions Plc

Healthcare Provider IT Services Service Provider Landscape with Services PEAK Matrix Assessment 2017

Synthetic Non-Biodegradable Polymers:

Wacker Chemie AG Industry meets Start-ups

NEXT GENERATION ECM-BASED ALLOGRAFT TECHNOLOGY:

2016 North American Cell Therapeutics Technology Innovation Award

Nick Pennell. Experience: Cost Reduction & Performance Improvement

Sustainable Growth: Biobased Fuels and Materials at DuPont. Mark A. Harmer DuPont, Wilmington, DE

STRATEGIC UPDATE 2014 TJERK DE RUITER, EDDY VAN RHEDE VAN DER KLOOT, SVEN THORMAHLEN

Brunei Darussalam Country Report

The role of Biomass in Renewable Energy Sources and its potential for green house gas reduction

Highly commoditized, low margin business, cyclical

Solvay, Enabling tomorrow

Global Life Sciences BPO Market to be Worth USD 596 Billion by 2019: Transparency Market Research

European Technology Platform for Sustainable Chemistry - The Smart Energy Home

SAMPLE. Mexico Orthopedic Prosthetics Market Outlook to Reference Code: GDMECC0156DB. Publication Date: February 2014

Singapore nanotechnology combats fatal brain infections

Our strategy 18 NOKIA IN 2016

DOE EERE and OS Funded Research: Deployment of the Biorefinery

Energy Trust of Oregon Strategic Plan

Digital transformation separating myths from reality

Nevi Event 10 Oktober -Een kijkje in de DSM inkoopkeuken- Ron van den Akker Vice President Purchasing Indirect

Bioeconomy Transformation summary of the bioeconomy activities at VTT

Future Roadmap for Industry of Surgical Instruments of Pakistan Basit Rauf Director TDAP Sialkot

DSM Sustainability Introduction. DSM Corporate Sustainability 2017

The Water-Energy-Food Nexus from the Food perspective

Limburg and its open innovation policy on the Brightlands campusses. Prof. dr. Martin Paul President Maastricht University

To unleash LeasePlan s potential in an exciting and dynamic market, we have defined a three-year strategic plan. Our strategic plan has three goals:

Holland Innovation Network Team Boston: Walter de Wit Julia Knoeff

The innovative biobased economy in Europe: value, partnerships & investments

Everest Group PEAK Matrix for Healthcare Payer IT Service Providers

The Forest Products Laboratory Research and Development USDA Forest Service

CIO Innovation management best practices DSM and its approach to innovation management

BioEnergy International, LLC. a Biorefinery Company

Business Overview 2017

CONTRIBUTION OF THE ETHANOL INDUSTRY TO THE ECONOMY OF THE UNITED STATES

Q-Sensors. Your world on a sensor

The Renewable Fuel Standard

Axel Hoos, M.D., Ph.D., SVP, Therapeutic Area Head for Oncology R&D and Head of Immuno Oncology, GSK

Managing Innovation and Entrepreneurship Spring 2008

Company Update. Induct AS. January 24 th 2017

Maximizing Market Access: THE 5 MOST CRITICAL QUESTIONS TO ASK WHEN LAUNCHING A SPECIALTY DRUGS

Biomaterials. Innovating for the future Markus Mannström EVP, Biomaterials division

nuplas BRINGING PLA TO MARKET


Biopharmaceuticals Investor & Analyst Day

Horizon H2020 Training for TECPAR Opportunities to participate in European Research Projects

CellaVision AB AGM Zlatko Rihter CEO & President CellaVision

Neue Generation von Textilfasern durch Recycling von Baumwollstoffen. Lenzing AG, S. Möderl

The Mochida Pharmaceutical Group s Medium Term Management Plan

Smart City Development in the USA

Wednesday October 14, Invitation only. For more information, please visit

The digitalized forestry ecosystem - fuelled by digital twins

EvaluateMedTech has used a number of sources within the site to develop a 4-level classification tree based on the FDA approvals process.

RENEWABLE ENERGY INSURANCE WE RE BIG ON A CLEANER FUTURE

BRIC Surgical Sutures Market Outlook to 2020

Biorefinery Mikael Hannus / October 22, 2010

DSM China Integrated Annual Report 2015

The sunliquid process - cellulosic ethanol from agricultural residues. Dr. Ing. Paolo Corvo Biotech & Renewables Center

Transcription:

Managing Sustainable Breakthrough Innovation Herman Wories VP Global Business Incubator DSM Innovation Center Barcelona 27 th February 2014

DSM Biomedical materials improve over 4.4 million people s lives, every day.

Aspirations and Metrics If you don t imagine it, it won t get done S. Lydenberg If you can t measure it, you can t manage it P. Drucker 3 Page

People People+ Health Food & Nutrition Security Sustainable Innovation Themes a Sustainable Company Profit Planet Energy Security Eco+ Sustainable Manufacturing/ Raw Materials

Building an intrinsically innovative company 20% Top Quartile McKinsey Innovation Benchmark 2012 Innovation Sales 2015 1B @ ~5% higher Gross Margins Disruptive Platforms, 2020

Fuzzy Front End Value Creation by Open Innovation Open innovation is no longer a competitive advantage. It has become a competitive necessity! Market Scouting, Business Intelligence Supplier driven innovation Joint Business Developments Licensing In Venturing Public, Private Partnerships Spin in Acquisitions, Alliances / JVs Interaction / Synthesis ODI Divestments Crowdsourcing R&D services (Chemelot) Licensing Out Spin out/off Competence Development, Technology Intelligence Intellectual Asset Management

Turning the pipeline into a bowling alley of opportunities Clear Front End

Market Maturity Decline Emerging Manage portfolio of innovations Renew & Grow existing position Red Box Explore & Build Maintain & Strengthen existing position Expand to adjacent markets Existing New Disruptiveness

Red box assessment: How good will we be able to execute? Market Attractiveness Ability to Execute

Red box experience Venture/project life cycle Market Attractiveness Original assessment and plan Learning the details Evaluate and adapt Ability to Execute

Blue box examples..

The first natural, scientifically substantiated solution for healthy blood flow EFSA (proprietary) health claim: Fruitflow helps maintain normal platelet aggregation, which contributes to healthy blood flow FiSA 2012 : Fruitflow one of the most innovative products of the year People+ Page 13

Maxilact The freedom to enjoy dairy Lactose free is one of the fastest growing segments in dairy, driven by increasing awareness of lactose intolerance and health & wellness trend. Maxilact breaks down lactose in dairy products, making them suitable for lactose intolerant consumers. DSM was the first company to commercialize lactase and has been innovating ever since to meet today s and tomorrow s lactase needs. People+

Arnitel Eco A high performance thermoplastic elastomer Partially made from renewable resources, using rapeseed oil. Adding new performances, like UV and heat resistance Panliners of Arnitel Eco, lowering the carbon footprint enabling higher temperatures Eco+ Page

Brewers Clarex Natural beer stabilization system for extended shelf life With DSMs Brewers Clarex CO2 emissions from brewing 1 hectoliter of beer are reduced between 5 and 8% Every December, in the UK a billion pints of beer are being sold Eco+ Page 16

Red box examples..

Managing breakthrough innovation DSM Innovation Center New Business Development Enablers / Accelerators EBA Biomedical Excellence in Innovation EBA Bio-based Products & Services EBA Advanced Surfaces CTO Office Licensing Business Incubator Venturing

Three exciting growth platforms established DSM Biomedical Innovative materials that enable more advanced clinical procedures and improved patient outcomes DSM Bio-based products & Services Advanced Enzymes and Yeast platforms: enabling Advanced Bio-Energy and Biobased chemicals DSM Advanced Surfaces Smart coatings and surface technologies to boost performance in the solar industry

20 DSM Bio-based Products & Services Eco+

Why Renewable Energy? The Fossil Age Living off the land A brief moment in history, the Fossil age Living off the land

Current major Biomass Ventures Cellulosic bio-ethanol Renewable diesel + Advanced Biogas Partner + Bio-Succinic

Enabling Advanced Biofuels POET & DSM: two innovative leaders one shared vision Making cellulosic ethanol competitive to grain ethanol Building Project LIBERTY ($250 Mln investment) in Emmetsburg, Iowa

People+ DSM Biomedical

Materials evolution Treatment moves from repair to healing BIO-PASSIVE Medical coatings and polymers BIO-ACTIVE Resorbable polymers and Drug Delivery BIO-INTERACTIVE Therapeutic materials, Regenerative medicine Material stays in the body Highly durable Maintaining mechanical properties over years Controlled drug release Disappears after use Healing by stimulation and growth of patients own tissue Disappears over time Cardio Orthopedic CMF Ophthalmology Orthopedic Orthopedic Orthopedic Pacemaker leads Hip implants Bone cement Back-of-the-eye medication Resorbable screws tendon repair Cartilage repair Stimulation of Bone growth

A world class portfolio of biomedical materials Silicone hydrogels Biomedical polyurethanes UHMWPE biomaterials Drug delivery Coatings Natural Materials Mechanical Devices ECMs Polymers & Metals Bio Commercialization

Biomaterials history at DSM PTG Acquisition (est. 1989) Start of DSM Dyneema s Medical R&D Efforts Official launch of Dyneema Purity orthopedic sutures Biomedical EBA launched First cardiovascular and ophthalmic drug delivery development agreements First sales of Dyneema Purity fiber in cardiovascular and spinal applications DSM targets EBA sales in 2020 > 1bn Expanded portfolio for ophthalmic applications Kensey Nash Acquisition 2000 2002 2004 2006 2008 2010 2012 Medical Coatings R&D efforts started in DSM Desotech First sales of Dyneema Purity fiber for knee ligament fixation First sales Medical Coatings Start of UH and Drug Delivery activities BMM Public Private Partnership funded by Dutch government Medivas technology acquisition for Drug Delivery Bionate II PCU Antimicrobial Coatings Next generation UH product VitroStealth nonbiofouling coatings Actamax DSM-DuPont JV HQ move to Berkeley, CA

Open Innovation in biomedical materials Joint R&D Joint Business Developments Licensing In Venturing Spin in Actamax Joint-venture Acquisitions Divestments R&D services Licensing Out Spin out/off Device design; Exclusive material developments Scientific Advisory Board & other Consultants

Summary: Managing Sustainable Breakthrough Innovation Sustainable Company WHY Sustainable Innovation Themes Building an intrinsically innovative company HOW Blue & Red Box Open Innovation Innovative solutions that improve, nourish and protect WHAT Growth Platforms